Convergent evidence from mouse and human studies suggests the involvement of zinc finger protein 326 gene in antidepressant treatment response

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Liou, Ying Jay ^a,b   Chen, Chien Hsiun ^c,d   Cheng, Chih Ya ^b   Chen, Shiow Yi ^e   Chen, Tai Jui ^f   Yu, Younger W Y ^f   Nian, Fang Shin ^b   Tsai, Shih Jen ^a,b   Hong, Chen Jee ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN OCEAN UNIVERSITY   (Taiwan)

^f Yu's Psychiatric Clinic   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; FLUOXETINE; MESSENGER RNA; SODIUM CHLORIDE; ANTIDEPRESSANT AGENT; DNA BINDING PROTEIN; NUCLEAR PROTEIN; SEROTONIN UPTAKE INHIBITOR; TRANSCRIPTION FACTOR; ZFP326 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; C57BL 6 MOUSE; CONTROLLED STUDY; CORPUS STRIATUM; DOWN REGULATION; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MECHANISM; FORCED SWIMMING TEST; FRONTAL CORTEX; FVB NJ MOUSE; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; HUMAN; HYPOTHALAMUS; IMMOBILIZATION; INTRON; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; OPEN FIELD TEST; QUANTITATIVE TRAIT LOCUS MAPPING; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STRAIN DIFFERENCE; THALAMUS; TREATMENT DURATION; TREATMENT RESPONSE; ZINC FINGER PROTEIN 326 GENE; ADULT; AGED; ANIMAL; ANIMAL BEHAVIOR; BRAIN; CASE CONTROL STUDY; DRUG EFFECT; EXON; FEMALE; GENETIC POLYMORPHISM; GENETICS; METABOLISM; MIDDLE AGED; QUANTITATIVE TRAIT LOCUS; REPRODUCIBILITY; SPECIES DIFFERENCE; SWIMMING; TREATMENT OUTCOME;

MUS;

ADULT; AGED; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BRAIN; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; DNA-BINDING PROTEINS; EXONS; FEMALE; FLUOXETINE; GENE EXPRESSION REGULATION; HUMANS; MALE; MICE; MIDDLE AGED; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; QUANTITATIVE TRAIT LOCI; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; SEROTONIN UPTAKE INHIBITORS; SPECIES SPECIFICITY; SWIMMING; TRANSCRIPTION FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84861646665     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032984     Document Type: Article

References (49)

1. Bauer M, Whybrow PC, Angst J, Versiani M, Moller HJ, (2002) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder. World J Biol Psychiatry 3: 5-43.
2. Entsuah AR, Huang H, Thase ME, (2001) Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo. J Clin Psychiatry 62: 869-877.
3. Thase ME, (2003) New approaches to managing difficult-to-treat depressions. J Clin Psychiatry 64 (Suppl 1): 3-4.
4. Thase ME, (2003) Effectiveness of antidepressants: comparative remission rates. J Clin Psychiatry 64 (Suppl 2): 3-7.
5. Thase ME, Haight BR, Richard N, Rockett CB, Mitton M, et al. (2005) Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials. J Clin Psychiatry 66: 974-981.
6. O'Reilly RL, Bogue L, Singh SM, (1994) Pharmacogenetic response to antidepressants in a multicase family with affective disorder. Biol Psychiatry 36: 467-471.
7. Pare CM, Mack JW, (1971) Differentiation of two genetically specific types of depression by the response to antidepressant drugs. J Med Genet 8: 306-309.
8. Pare CM, Rees L, Sainsbury MJ, (1962) Differentiation of two genetically specific types of depression by the response to anti-depressants. Lancet 2: 1340-1343.
9. Lerer B, Macciardi F, (2002) Pharmacogenetics of antidepressant and mood-stabilizing drugs: a review of candidate-gene studies and future research directions. Int J Neuropsychopharmacol 5: 255-275.
10. Makalowski W, Boguski MS, (1998) Evolutionary parameters of the transcribed mammalian genome: an analysis of 2,820 orthologous rodent and human sequences. Proc Natl Acad Sci U S A 95: 9407-9412.
11. Tecott LH, Wehner JM, (2001) Mouse molecular genetic technologies: promise for psychiatric research. Arch Gen Psychiatry 58: 995-1004.
12. Tecott LH, (2003) The genes and brains of mice and men. Am J Psychiatry 160: 646-656.
13. Watters JW, McLeod HL, (2003) Using genome-wide mapping in the mouse to identify genes that influence drug response. Trends Pharmacol Sci 24: 55-58.
14. Tomida S, Mamiya T, Sakamaki H, Miura M, Aosaki T, et al. (2009) Usp46 is a quantitative trait gene regulating mouse immobile behavior in the tail suspension and forced swimming tests. Nat Genet.
15. Yalcin B, Willis-Owen SA, Fullerton J, Meesaq A, Deacon RM, et al. (2004) Genetic dissection of a behavioral quantitative trait locus shows that Rgs2 modulates anxiety in mice. Nat Genet 36: 1197-1202.
16. Crowley JJ, Brodkin ES, Blendy JA, Berrettini WH, Lucki I, (2006) Pharmacogenomic evaluation of the antidepressant citalopram in the mouse tail suspension test. Neuropsychopharmacology 31: 2433-2442.
17. Liu X, Stancliffe D, Lee S, Mathur S, Gershenfeld HK, (2007) Genetic dissection of the tail suspension test: a mouse model of stress vulnerability and antidepressant response. Biol Psychiatry 62: 81-91.
18. Borsini F, Meli A, (1988) Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology (Berl) 94: 147-160.
19. Lucki I, Dalvi A, Mayorga AJ, (2001) Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology (Berl) 155: 315-322.
20. Cheng AT, Tien AY, Chang CJ, Brugha TS, Cooper JE, et al. (2001) Cross-cultural implementation of a Chinese version of the Schedules for Clinical Assessment in Neuropsychiatry (SCAN) in Taiwan. Br J Psychiatry 178: 567-572.
21. Hong CJ, Chen TJ, Yu YW, Tsai SJ, (2006) Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder. Pharmacogenomics J 6: 27-33.
22. Liou YJ, Chen TJ, Tsai SJ, Yu YW, Cheng CY, et al. (2009) Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment. Pharmacogenet Genomics 19: 735-741.
23. Tsai SJ, Liou YJ, Hong CJ, Yu YW, Chen TJ, (2008) Glycogen synthase kinase-3beta gene is associated with antidepressant treatment response in Chinese major depressive disorder. Pharmacogenomics J 8: 384-390.
24. Yu YW, Tsai SJ, Chen TJ, Lin CH, Hong CJ, (2002) Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Mol Psychiatry 7: 1115-1119.
25. Serretti A, Kato M, Kennedy JL, (2008) Pharmacogenetic studies in depression: a proposal for methodologic guidelines. Pharmacogenomics J 8: 90-100.
26. Della Beffa C, Klawonn F, Menetski JP, Schumacher HR, Pessler F, (2011) Evaluation of glyceraldehyde-3-phosphate, prolylpeptidyl isomerase A, and a set of stably expressed genes as reference mRNAs in urate crystal inflammation. BMC Res Notes 4: 443.
27. Kobayashi MS, Takahashi Y, Nagata T, Nishida Y, Murata A, et al. (2004) Screening for control genes in rat global cerebral ischemia using high-density oligonucleotide array. J Neurosci Res 76: 512-518.
28. Thal SC, Wyschkon S, Pieter D, Engelhard K, Werner C, (2008) Selection of endogenous control genes for normalization of gene expression analysis after experimental brain trauma in mice. J Neurotrauma 25: 785-794.
29. Pernot F, Dorandeu F, Beaup C, Peinnequin A, (2010) Selection of reference genes for real-time quantitative reverse transcription-polymerase chain reaction in hippocampal structure in a murine model of temporal lobe epilepsy with focal seizures. J Neurosci Res 88: 1000-1008.
30. Leduc V, Legault V, Dea D, Poirier J, (2011) Normalization of gene expression using SYBR green qPCR: A case for paraoxonase 1 and 2 in Alzheimer's disease brains. J Neurosci Methods 200: 14-19.
31. Feroze-Merzoug F, Berquin IM, Dey J, Chen YQ, (2002) Peptidylprolyl isomerase A (PPIA) as a preferred internal control over GAPDH and beta-actin in quantitative RNA analyses. Biotechniques 32: 776-778, 780, 782.
32. Suzuki T, Higgins PJ, Crawford DR, (2000) Control selection for RNA quantitation. Biotechniques 29: 332-337.
33. Broman KW, Wu H, Sen S, Churchill GA, (2003) R/qtl: QTL mapping in experimental crosses. Bioinformatics 19: 889-890.
34. Zeng ZB, (1993) Theoretical basis for separation of multiple linked gene effects in mapping quantitative trait loci. Proc Natl Acad Sci U S A 90: 10972-10976.
35. Zeng ZB, (1994) Precision mapping of quantitative trait loci. Genetics 136: 1457-1468.
36. Lander E, Kruglyak L, (1995) Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11: 241-247.
37. Arnett DK, Pankow JS, Atwood LD, Sellers TA, (1997) Impact of adjustments for intermediate phenotypes on the power to detect linkage. Genet Epidemiol 14: 749-754.
38. David DJ, Renard CE, Jolliet P, Hascoet M, Bourin M, (2003) Antidepressant-like effects in various mice strains in the forced swimming test. Psychopharmacology (Berl) 166: 373-382.
39. Petit-Demouliere B, Chenu F, Bourin M, (2005) Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berl) 177: 245-255.
40. Falconer DS, Mackay FC, (1996) Introduction to Quantitative Genetics: Prentice Hall.
41. Lee JY, Nakane Y, Koshikawa N, Nakayama K, Hayashi M, et al. (2000) Characterization of a zinc finger protein ZAN75: nuclear localization signal, transcriptional activator activity, and expression during neuronal differentiation of P19 cells. DNA Cell Biol 19: 227-234.
42. Krishnan V, Nestler EJ, (2008) The molecular neurobiology of depression. Nature 455: 894-902.
43. Nembaware V, Lupindo B, Schouest K, Spillane C, Scheffler K, et al. (2008) Genome-wide survey of allele-specific splicing in humans. BMC Genomics 9: 265.
44. Schadt EE, Molony C, Chudin E, Hao K, Yang X, et al. (2008) Mapping the genetic architecture of gene expression in human liver. PLoS Biol 6: e107.
45. Uher R, Perroud N, Ng MY, Hauser J, Henigsberg N, et al. (2010) Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. Am J Psychiatry 167: 555-564.
46. Lee JY, Kambe M, Hayashi M, Takenaga K, (1998) Cloning and characterization of a novel zinc finger protein that associates with nuclear matrix. DNA Cell Biol 17: 849-858.
47. O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, et al. (2008) Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 40: 1053-1055.
48. Williams HJ, Norton N, Dwyer S, Moskvina V, Nikolov I, et al. (2011) Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol Psychiatry 16: 429-441.
49. Crowley JJ, Jones MD, O'Leary OF, Lucki I, (2004) Automated tests for measuring the effects of antidepressants in mice. Pharmacol Biochem Behav 78: 269-274.